prof. MUDr. Jiří Mayer, CSc.
Department head, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3643, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 1627
2024
-
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
American Journal of Hematology, year: 2024, volume: 99, edition: 4, DOI
-
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia
Blood advances, year: 2024, volume: 8, edition: 7, DOI
-
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
Leukemia, year: 2024, volume: 38, edition: 5, DOI
-
MethScore as a new comprehensive DNA methylation-based value refining the prognosis in acute myeloid leukemia
CLINICAL EPIGENETICS, year: 2024, volume: 16, edition: 1, DOI
-
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study
Journal of clinical oncology, year: 2024, volume: 42, edition: 5, DOI
-
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes
Blood advances, year: 2024, volume: 8, edition: 10, DOI
-
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
British journal of haematology, year: 2024, DOI
-
Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trial
Current medical research and opinion, year: 2024, DOI
-
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment
Year: 2024, type: Article in Periodical (without peer review)
-
Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study
JOURNAL OF HEMATOLOGY & ONCOLOGY, year: 2024, volume: 17, edition: 1, DOI